Introduction
The benefits of using acellular dermal matrices (ADMs) in implant-based breast reconstruction have recently been reported both for primary reconstructions as well as revisionary procedures. Techniques using ADMs in these settings have been shown to assist in controlling implant position by defining the inframammary fold (IMF) and lateral mammary fold (LMF). In addition, they may provide a decreased risk of capsular contracture and may be used in the management of already developed contractures. The purpose of this chapter is to review the newest trends in the use of ADMs in implant-based breast reconstruction. A direct-to-implant approach to primary breast reconstruction following nipple-areola sparing mastectomy (NASM) is detailed and the revisionary procedures highlighted include the correction of implant malposition and the management of capsular contracture.
Primary reconstruction
Immediate direct-to-implant breast reconstruction after skin-sparing or NASM (Breuing & Warren, 2005; Breuing & Colwell, 2007; Cassileth et al., 2011; Salzberg, 2006; Salzberg et al., 2011; Topol et al., 2008; Wang et al., 2008; Zienowicz & Karacaoglu, 2007) is gaining popularity as a viable alternative to immediate expander/implant reconstruction which is the current standard of care for implant-based breast reconstruction postmastectomy (American Society of Plastic Surgeons [ASPS], 2009). While both approaches allow immediate creation of the breast mound offering pyschologic and aesthetic benefits, the direct-to-implant approach allows maximal use of the preserved mastectomy skin at the time of reconstruction. This eliminates the need for serial tissue expansions and potentially avoids a second surgery.
The use of ADMs has greatly facilitated direct-to-implant as well as expander/implant reconstruction. By extending the reach of the pectoralis major muscle, ADMs not only provide complete coverage of the subpectorally placed implant or expander but they also increase the volume of the subpectoral pocket. In expander/implant reconstructions, the increased
Review of experience
The author's initial clinical experience with the use of ADM-assisted immediate direct-toimplant reconstruction following NASM consists of 47 reconstructions (24 therapeutic and 23 prophylactic) performed in 27 patients from January 2007 to June 2009 . Patients were selected to undergo ADM-assisted immediate direct-to-implant reconstruction if they were not candidates for or did not desire an autologous procedure. Patients had an average age of 49 years (range 27-72 years). During the early postoperative period (<30 days) complications occurred in 21 breasts and included mild nipple-areola skin slough (13), moderate nipple-areola skin slough (2), full-thickness nipple loss (2), cellulitis (3), and capsular contracture (1). All cases of nipple-areola skin slough were resolved with local care and all cases of cellulitis were resolved with oral antibiotics. There were no cases of device loss or failed reconstruction during an average follow-up period of 17 months (range 2-28 months). There was one case of NA occult tumor that required NA removal. Two patients required revisionary surgery; one patient underwent implant exchange as she desired a larger implant and the other underwent nipple reconstruction to regain nipple projection after nipple flattening. Our results suggest that ADM-assisted direct-to-implant breast reconstruction can be reliably accomplished after NASM and are in concordance with other published series of ADMassisted direct-to-implant reconstruction (Breuing & Warren, 2005; Breuing & Colwell, 2007; Cassileth et al., 2011; Salzberg, 2006; Salzberg et al., 2011; Topol et al., 2008; Zienowicz & Karacaoglu, 2007) .
The success of direct-to-implant reconstruction after NASM is dependent on proper patient selection. Patients with evidence of direct nipple involvement of tumor, Paget's disease, inflammatory breast cancer, tumor size > 3 cm, or tumor < 2 cm from nipple center may not be suitable candidates for NASM because of an increased risk of local tumor recurrence (Brachtel et al., 2009; Cunnick & Mokbel, 2006) . Following NASM, the quality of the preserved skin is an important consideration for direct-to-implant reconstruction because extremely thin skin or compromised skin increases the risk of ischemia and skin necrosis which can eventually lead to implant loss (Woerdeman et al., 2006) . Moreover, patients with preoperative macromastia or breast ptosis who undergo direct-to-implant reconstruction are at increased risk of perioperative complications and revisionary surgery (Roostaeian et al., 2011) . Further, age > 65 years and comorbid conditions such as smoking, obesity, and hypertension increase the risk of perioperative complications and the latter three also increase the risk of reconstructive failure (McCarthy et al., 2008) . Thus, a careful evaluation of these risk factors needs to be taken into consideration when selecting patients for directto-implant reconstruction.
Operative details
The use of ADM to extend the pectoralis major muscle at the lower pole to provide complete soft tissue coverage of the implant (Figure 1 ) has been previously described (Breuing & Warren, 2005; Salzberg, 2006; Zienowicz & Karacaoglu, 2007) . NASM is performed via a periareolar incision (Figures 2A & 2B) . In some patients, a lateral extension to the periareolar incision may be required to facilitate mastectomy. Following Fig. 1 . ADM placement at the inferolateral border of the implant. mastectomy, nipple coring is performed ( Figure 2C ) and specimens are taken and sent for permanent fixation and evaluation of tumor presence. Immediate reconstruction is then performed with subpectoral implant placement. The inferolateral origin of the pectoralis major muscle is elevated off the chest wall and a subpectoral pocket is created based on the dimensions of the previous breast perimeter and the desired implant size. The LMF is defined and marked on the chest wall in-continuity with the IMF. A prehydrated sheet of ADM (AlloDerm ® , human acellular dermal matrix, LifeCell Corporation, Branchburg, NJ) is then sutured to the chest wall using running 2-0 Vicryl sutures (Ethicon, Inc., Somerville, NJ) along the marked fold. The deep dermal side of the ADM is placed facing the overlying lower breast skin. An implant is introduced into the subpectoral pocket under the muscle. The ADM is then brought over the implant, tapered as needed, and secured to the free border of the pectoralis muscle using running 2-0 Vicryl sutures, completely covering the implant ( Figure 2D) . Mastectomy flaps are then tailored as necessary and closed in layers over two closed suction drains brought out laterally. One drain is placed between the ADM and the overlying skin at the IMF and a second drain is placed deep to the superior mastectomy skin. 
Patient cases

Case 1
Patient is a 53-year-old with the BRCA 2 genetic mutation and a family history of breast cancer. She opted to undergo prophylactic mastectomy with immediate implant-based breast reconstruction. Physical examination revealed no contraindications for NASM. She had nearly symmetric B-cup breasts with grade 2 ptosis ( Figure 3 ). Patient underwent NASM via the supra-areolar approach. Immediate ADM-assisted, direct-to-implant breast reconstruction was performed with 400 cc, smooth round gel implants. Her postoperative course was uneventful. At 11-month follow-up, she exhibited good symmetry, lower-pole projection, and volume match compared with preoperative size with well-camouflaged periareolar scars. Fig. 3 . A 53-year-old patient who underwent bilateral prophylactic mastectomy via the supra-areolar approach and received smooth round gel implants. Her postoperative course was uneventful. Postoperative: at 11 months follow-up.
Case 2
Patient is a 46-year-old diagnosed with right invasive ductal carcinoma. She elected to undergo right therapeutic mastectomy and left prophylactic mastectomy. There were no contraindications to proceeding with NASM. She had bilateral B-cup breasts with a slightly more ptotic right side. Patient underwent bilateral NASM via the supra-areolar approach with immediate ADM-assisted breast reconstruction using 325 cc smooth round gel implants. She had an uneventful postoperative course. At 4-month follow-up, she had good implant position, breast symmetry, and a well-healed periareolar scar. 
Revisionary procedures
Implant-based reconstruction is the most widely used approach to breast reconstruction postmastectomy because of its simplicity (ASPS, 2009). As opposed to autologous procedures, it is technically less demanding, has shorter operative times, results in brief hospital stays, has decreased short-term costs, and has no associated donor site morbidity (Ahmed et al., 2005) . In addition, good to excellent aesthetic outcomes and high patient satisfaction have been reported with this approach (Cordeiro & McCarthy, 2006) . Despite these benefits, implant-based reconstruction is not without concerns; it is associated with a high rate of implant-related complications notably capsular contracture, implant malposition, asymmetry, and rippling (Cunningham & McCue, 2009; Handel et al, 2006; Spear et al, 2007) . Consequently, rates of revisionary surgery are also high; approximately 34%-52% of reconstruction patients undergo revision surgery within 3-6 years of their primary procedure and 36% of revision reconstruction patients undergo further revisionary surgery (Cunningham & McCue, 2009; Handel et al, 2006; Spear et al, 2007) .
Corrective techniques for capsular contracture, implant malposition, and rippling have traditionally involved capsulotomy or capsulectomy, implant pocket change, implant replacement, use of capsular flaps, or a combination of these (Baxter, 2003; ). These techniques, however, have not always been reliable and recurrence is common (H. Becker et al, 2005; Chasan & Francis, 2008; Massiha, 2002; Spear et al., 2003) . Given the safety, efficacy, and aesthetic results obtained with the use of ADM in primary breast reconstruction, there is an emerging trend to use ADM for the correction and prevention of implant-related complications in both reconstructive and aesthetic patients. The feasibility of using ADM for the correction of visible implant rippling and breast deformities due to implant malposition was initially reported almost a decade ago in breast reconstruction and aesthetic patients (Baxter, 2003; Duncan, 2001) . Since then several studies have demonstrated a significant reduction in recurrence and improved cosmesis with the use of ADM for the correction of capsular contracture, implant malposition, and rippling (Breuing & Colwell, 2007; Grabov-Nardini et al., 2009; Hartzell et al., 2010; Spear et al., 2011) . Overall, > 87% of implant-related complications were successfully managed using ADMs. Although promising, it should be noted that the followup period in most of these studies was relatively short averaging 9-12 months which may not be sufficiently long to evaluate recurrence rates.
Correction of implant malposition
Implant malposition manifesting as inferior, medial (symmastia), or lateral malposition is a commonly encountered complication of implant-based reconstructions. In primary reconstruction patients, a 20% reoperation rate due to implant malposition has been reported over a 6-year period (Spear et al., 2007) . A number of factors may cause implant malposition including inadequate or excessive pocket dissection; overzealous release of the IMF, lateral and/or medial release of breast tissues, or lateral and/or medial release of the pectoralis major muscle; placement of excessively large implants; or attenuated capsular tissues (Baxter, 2003) . Traditional approaches to surgical correction of implant malposition have included capsulorrhaphy with or without mirror-image capsulotomy (Chasan, 2005; Chasan & Francis, 2008; Spear & Little, 1988) , implant site change from subglandular to subpectoral or subpectoral to neosubpectoral Spear et al., 2009) , and use of an adjustable implant (H. Becker et al., 2005) . These approaches are often technically demanding and not always reliable (Spear et al., 2011) . Capsulorrhaphy, the mainstay of corrective surgery, often does not sufficiently prevent the implant from falling against the suture line or moving across it (Voice & Carlsen, 2001) . Consequently, reinforcement of the suture line with capsular flaps has been attempted (Voice & Carlsen, 2001 ) and a recent case study has noted success with this technique, albeit with a short follow-up period of 3-6 months (Yoo & Lee, 2010) . However, capsular flaps have limited applicability in patients with attenuated capsules who are unlikely to have adequate tissue. As an alternative to capsular flaps, recent studies have advocated the use of ADM to reinforce the capsulorrhaphy suture line and maintain the implant within its pocket Hartzell et al., 2010; Spear et al., 2011) . In addition, the use of ADM also helps to redefine the IMF and LMF. Successful correction of implant malposition has been reported with the use of ADM with good aesthetic results, no recurrence, and minimal complications and failures.
Review of experience
The author's initial clinical experience with the correction of implant malposition with ADM assistance is derived from 12 patients who collectively had 21 inferior and lateral implant malpositions . Patients were treated between December 2009 and March 2010. All patients underwent corrective surgery as described below with ADM reinforcement of the capsulorrhaphy suture line. Patients have been followed for a mean of 7 months (range 3-15 months) with no evidence of complications or recurrences. Proper implant position was reestablished in all patients with well-defined folds.
Operative details
The technique of using ADM to reinforce fold correction after capsulorrhaphy has been recently reported (Spear et al., 2011) . The essential steps of corrective surgery include fold recreation by capsulorrhaphy, reinforcement of the fold with overlapping ADM secured to capsule, and pocket size correction, including mirror image capsulotomy when necessary ( Figure 5 ).
Preoperatively, planned capsulorrhaphy fold correction and IMF position are marked with the patient in the upright standing position (Figure 6 ). The implant is accessed and removed via the previous mastectomy incision. If needed, the new IMF location can be r e m a r k e d i n t r a o p e r a t i v e l y w i t h t h e h e l p o f 2 5 -g a u g e n e e d l e s ( F i g u r e s 7 A & 7 B ) . A capsulorrhaphy is then performed to create the new IMF and LMF with several rows of running 0-TiCron TM sutures (Covidien, Mansfield, MA) to the chest wall ( Figure 7C ). The desired fold location can be verified with the help of a sizer or implant. If needed, a superior capsular incision is made along the entire superior aspect of the breast to allow for improved implant positioning. The newly created IMF and lMF positions are then reinforced with a sheet of prehydrated ADM (AlloDerm) ( Figure 7D ). The ADM is placed over the fold suture line, with its deep dermal side facing the skin flaps, overlapping ~1.5 to 2 cm on either side of the repair. It is secured with multiple interrupted or with running 2-0 Vicryl sutures through the capsule to the chest wall posteriorly and to the capsule over the anterior surface along the entire length of the IMF and LMF. A new implant is introduced into the pocket and muscle, capsule, and skin closure are performed completing the corrective surgery (Figure 8) . 
Patient cases
Case 3
A 48-year-old woman with a history of lobular carcinoma in situ presented with inferior implant malposition, breast asymmetry, and severe implant rippling at the superomedial aspect of her breasts after second stage bilateral tissue expander/implant reconstruction (Figure 9 ). Her implant-related problems were due to loss of IMFs and LMFs. To address these, she underwent bilateral recreation of the folds by capsulorrhaphy. Because she had thinned tissue, her native tissues were insufficient to reinforce the folds and ADM was used to reinforce the folds. An implant exchange was also performed and her silicone implants (450 cc) were replaced with slightly larger silicone implants (475 cc) to better fit the pocket size correction. The larger implants would also help toward reducing rippling. At 7 months post-revisionary surgery, the patient exhibited well-proportioned, symmetrical breasts with good contour as a result of well-defined IMFs and LMFs. Implant rippling was greatly reduced. Fig. 9 . Preoperative stage: patient presented with implant malposition, asymmetry, and significant implant rippling after second stage bilateral tissue expander/implant breast reconstruction. Postoperative stage: at 7 months of follow-up (with interim nipple-areola reconstruction) after correction of implant malposition using the technique described. The IMF and LMF are well-defined and rippling is improved.
Case 4
A 45-year-old woman with a history of left breast cancer presented with implant malposition and significant rippling after first stage bilateral tissue expander breast reconstruction. She was found to have inferior and lateral implant malposition as well as excess breast skin laxity with rippling. She underwent bilateral IMF and LMF correction with capsulorrhaphy. Each fold repair was reinforced with ADM and the breast skin www.intechopen.com Acellular Dermal Matrix for Optimizing Outcomes in Implant-Based Breast Reconstruction: Primary and Revisionary Procedures 103 envelope was tapered to accommodate 450 cc silicone gel implants. At 7 months after undergoing expander-implant exchange with revision reconstruction, the patient is found to have good breast contour and symmetry. Due to the improved balance between her breast skin, fold placement and implant position, her rippling is markedly reduced. Fig. 10 . Preoperative stage: patient presented with implant malposition and significant rippling after first stage bilateral tissue expander breast reconstruction. Postoperative stage: at 7 months of follow-up (with interim nipple-areola reconstruction) after correction of implant malposition using the technique described. The IMF and LMF are well-defined and rippling is improved.
Correction of capsular contracture
Capsular contracture is the most common complication associated with implant-based breast reconstruction (Adams, 2009) . Core clinical studies from device manufacturers have reported a 6-year cumulative incidence of capsular contracture rate of 14%-16% in primary and 25% in revision reconstruction patients (Cunningham & McCue, 2009; Spear et al., 2007) . Capsular contracture was also the most common reason for revisionary surgery in these studies.
The true cause of capsular contracture is unknown. Current evidence suggests that subclinical infection with biofilm-forming or nonbiofilm-forming bacteria may be a primary cause. A causal link between subclinical infection, biofilm formation, and capsular contracture has been demonstrated in a recent porcine study (Tamboto et al., 2010) . Irrespective of the cause of capsular contracture, it is believed that inflammation at the cellular level eventually leads to pathologic capsular contracture (Adams, 2010) . Support for this hypothesis comes from a clinical study where foreign body inflammatory response in capsular tissue was shown to be directly correlated to capsule thickness and Baker score (Prantl et al., 2007) .
Traditionally, corrective surgery for capsular contracture has entailed open capsulotomy or partial/total capsulectomy, followed by implant site change, and implant exchange , although this does not always prevent recurrence. More recently, ADMs have been used at the inferolateral pole after capsulotomy or capsulectomy to help correct and prevent capsular contracture (Breuing & Colwell, 2007; Hartzell et al., 2010; Spear et al., 2011) . In ADM-assisted implant-based primary reconstructions, a low rate of capsular contracture (0%-2%) has been observed (S. Becker et al., 2009; Bindingnavele et al., 2007; Breuing & Colwell, 2007; Namnoum, 2009; Salzberg, 2006; Salzberg et al., 2011; Spear et al., 2008; Zienowicz & Karacaoglu, 2007) , suggesting that ADMs may help prevent or reduce the risk of capsular contracture; hence, the rationale for using ADMs for the correction and prevention of capsular contracture. Animal and clinical studies suggest that ADMs may prevent capsular contracture by minimizing the inflammatory response, thereby reducing capsule formation around implants (Basu et al., 2010; Komorowska-Timek et al., 2009; Orenstein et al., 2010; Stump et al., 2009; Uzunismail et al., 2008) . Published series have reported successful correction of > 90% of grade 3/4 capsular contractures with the use of ADMs with no recurrences during a mean follow-up period of 9-21 months (Breuing & Colwell; Hartzell et al., 2010; Spear et al., 2011) .
Review of experience
Between November 2005 and April 2010, the author used ADM for the correction of capsular contracture (grade 3 or 4) in 18 patients (21 breasts) (Israeli, 2011) . All patients developed capsular contracture after tissue expander/implant reconstruction postmastectomy. Nine breasts had received prior radiotherapy. During a follow-up period of 3-43 months, initial successful correction of capsular contracture (ie, achievement of grade ≤ 2) was noted in 17 patients. There was 1 case of early post-operative cellulitis requiring oral antibiotics in a patient with a history of radiotherapy who later developed recurrent contracture. There were no cases of implant loss.
Operative details
We have previously described the technique of using ADM for the correction of capsular contracture (Israeli & Feingold, 2011) which is essentially the same as for a primary reconstruction (Figure 1 ). Key steps of corrective surgery include capsulectomy, expansion of implant pocket using a sheet of ADM, and redefining the IMF and LMF. Using the previous mastectomy incision, the implant or expander is accessed and removed. A circumferential capsulotomy is performed around the implant pocket at the level of the chest wall and the inferolateral border of the pectoralis major muscle is mobilized. A partial anterior capsulectomy is performed, the extent of which depends on capsule thickness, recreating the original inferolateral defect postmastectomy prior to primary reconstruction. Steps are then taken to correct this defect by recreating the IMF and LMF as in a primary reconstruction. A sheet of prehydrated ADM (AlloDerm) of standard thickness is utilized to recreate the inframammary and lateral mammary folds. The size of ADM used is dependent on the extent of capsulectomy performed. The ADM is placed at the inferolateral border of the breast and is secured laterally, inferiorly, and medially to the chest wall with 2-0 Vicryl sutures. The ADM is placed with the deep dermal side facing the inferior breast skin. A new implant is introduced into the pocket and with the patient in a sitting position proper implant and inframammary fold position are verified. The superior edge of the ADM is then sutured to the elevated lower border of the pectoralis major muscle or to the superior border of the capsulectomy defect. Through a separate lateral stab incision, one closed suction drain is placed along the inframammary fold between the ADM and the skin flap inferiorly where the capsulectomy was completed. Final incision closure is performed in standard fashion.
Patient cases
Case 5
A 44-year-old woman with a history of infiltrating ductal carcinoma and ductal carcinomain-situ on her right breast presented with right capsular contracture (grade 3) after first stage bilateral ADM-assisted expander reconstruction ( Figure 11A ). Capsular contracture developed secondary to radiotherapy. Corrective surgery for capsular contracture was performed in conjunction with second stage implant reconstruction and included capsulectomy ( Figure 11B ) followed by expansion of the implant pocket using a sheet of ADM (AlloDerm) and repositioning of the IMF ( Figure 11C ). On the left breast, excess skin was excised laterally to improve the breast contour during exchange. No complications occurred during a follow-up period of 10 months ( Figures 11D & 11E) . Capsular contracture was successfully treated and breast projection and ptosis on the irradiated side were wellmatched to the contralateral nonirradiated side. 
Case 6
A 46-year-old woman presented with early right capsular contracture (grade 3) and left inferior implant malposition after ADM-assisted implant reconstruction ( Figures 12A &  12B) . On her right breast, she underwent partial capsulectomy at the IMF ( Figure 12C ) followed by reinforcement of the capsulectomy site with ADM ( Figure 12D ) as corrective surgery for capsular contracture. On her left breast, she underwent capsulorrhaphy at the IMF and LMF ( Figure 12E ) with reinforcement of suture lines with ADM ( Figure 12F ) to address implant malposition. Both breasts were fitted with new implants. Four-month postoperative photographs showed correction of capsular contracture and inferior malposition ( Figures 12G-I ).
Conclusion
ADMs have become an integral part of implant-based breast reconstruction with the expectation that their use would result in low complication rates, improved aesthetic outcomes, and greater patient satisfaction. In the setting of immediate postmastectomy breast reconstruction, the ADM acts as an extension to the pectoralis muscle thereby allowing a direct-to-implant and potentially single-stage approach. This technique is particularly effective in patients that are candidates for NASM, where the entire breast skin envelope is preserved. Emerging evidence also indicates that ADMs may play a role in revisionary surgery assisting in reestablishing proper implant positioning and preventing capsular contracture. The ability of ADMs to fulfill these roles is attributed to their biomechanical properties of strength and pliability and biologic property of supporting tissue regeneration. 
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